Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Recro Pharma Inc (NASDAQ:REPH)

6.84
Delayed Data
As of May 04
 -0.048 / -0.70%
Today’s Change
5.59
Today|||52-Week Range
18.30
-24.00%
Year-to-Date
No recent news for Recro Pharma Inc.

Today’s Trading

Previous close6.89
Today’s open6.74
Day’s range6.74 - 6.90
Volume9,176
Average volume (3 months)17,463
Market cap$63.6M
Dividend yield--
Data as of 4:00pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,252.38%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio19.7
Price/Sales1.52
Price/Book1.56

Competitors

 Today’s
change
Today’s
% change
CASICASI Pharmaceuticals...+0.01+0.67%
RNNRexahn Pharmaceutica...+0.01+3.09%
PTXPernix Therapeutics ...-0.04-3.64%
OCRXOcera Therapeutics I...-0.14-4.58%
Data as of 4:00pm ET, 05/04/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$52.0M
Annual profit (last year)$3.0M
Net profit margin5.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gerri Henwood
Chief Financial Officer, CAO, VP &
Controller
Donna M. Nichols
Corporate headquarters
Malvern, Pennsylvania

Forecasts

Partner Offers

Search for Jobs